protein kinase C-theta inhibitors (Aqilion)

N/A

Report date: 2025/06/11 10:16:20
NME

Base Information

Drug Nameprotein kinase C-theta inhibitors (Aqilion)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionProtein kinase C theta inhibitors
TargetsProtein kinase C theta
Therapy Area/IndicationsInflammationAutoimmune DiseasesColitis, Ulcerative +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAqilion AB
China Registration ClassN/A

Develop Information

Active CompaniesAqilion AB
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune DiseasesColitis, Ulcerative +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A